CIBC Asset Management
PRAX icon

CIBC Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

CIBC Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Sell
862
-38
-4% -$12K ﹤0.01% 1077
2026
Q1 		$290K Hold
900
– – ﹤0.01% 1000
2025
Q4 		$265K Sell
900
-387,859
-100% -$72.2M ﹤0.01% 1045
2025
Q3 		$20.6M Hold
388,759
– – 0.06% 203
2025
Q2 		$16.3M Hold
388,759
– – 0.05% 233
2025
Q1 		$14.7M Buy
388,759
+22,003
+6% +$1.37M 0.05% 237
2024
Q4 		$28.2M Buy
366,756
+117,817
+47% +$8.52M 0.09% 147
2024
Q3 		$14.3M Buy
248,939
+56,272
+29% +$3.04M 0.05% 220
2024
Q2 		$7.97M Buy
192,667
+363
+0.2% +$17.2K 0.03% 301
2024
Q1 		$11.7M Buy
192,304
+18,436
+11% +$827K 0.04% 244
2023
Q4 		$3.87M Buy
173,868
+52,141
+43% +$939K 0.01% 410
2023
Q3 		$3.12M Buy
121,727
+19,695
+19% +$373K 0.01% 431
2023
Q2 		$1.76M Buy
102,032
+16,401
+19% +$251K 0.01% 571
2023
Q1 		$1.04M Buy
85,631
+60,322
+238% +$2.55M ﹤0.01% 659
2022
Q4 		$904K Buy
+25,309
New +$789K ﹤0.01% 678

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

CIBC Asset Management's PRAX Position: Q2 2026 in Review

CIBC Asset Management reduced its Praxis Precision Medicines (PRAX) stake by 4.2% in Q2 2026, selling an estimated $12K and leaving 862 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

CIBC Asset Management first reported a position in PRAX in Q4 2022 and has held it in 15 quarters since. The position peaked at $28.2M in Q4 2024. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • CIBC Asset Management held 862 shares of Praxis Precision Medicines worth $289K as of Q2 2026.
  • CIBC Asset Management sold 38 Praxis Precision Medicines shares in Q2 2026, an estimated $12K.
  • Praxis Precision Medicines made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #1077 holding.
  • CIBC Asset Management first reported a position in Praxis Precision Medicines in Q4 2022 and has held it in 15 quarters since.
  • CIBC Asset Management's Praxis Precision Medicines position peaked at $28.2M in Q4 2024.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.